Please Wait.....
Report
North America Genotyping Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product and Services (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology [Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others], Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Others)
Market Report I 2022-09-16 I 157 Pages I The Insight Partners
The genotyping market in North America is expected to grow from US$ 11,734.10 million in 2022 to US$ 37,599.28 million by 2028. It is estimated to grow at a CAGR of 21.4% from 2022 to 2028.
Genotyping compares a DNA sequence to another sample or a reference sequence to discover variations in genetic complement. It detects single-nucleotide polymorphisms (SNPs), which are minor differences in genetic sequence within the population. The human genome has about 660 million SNPs, making them the most prevalent kind of genetic variation. They can explain features such as eye color and hereditary disorders such as cystic fibrosis and sickle cell anemia and serve as indicators for developing complicated diseases, such as cancer, diabetes, and Alzheimer's.
According to the Alzheimer's Association, the number of people living with Alzheimer's in the US is rapidly increasing. Alzheimer's affects more than 6 million Americans of all ages. In 2022, an estimated 6.5 million Americans aged 65 and up have Alzheimer's, out of which 73% of the population is 75 years old or older. The introduction of high-throughput genotyping technologies has greatly advanced our understanding of the genetic components of complex disorders, such as T2D.
Additionally, by comparing polymorphisms in two distinct populations (one healthy and one diseased), genome-wide association studies (GWAS) can uncover links between SNPs and common illness risk. GWAS can begin to untangle the molecular mechanisms underlying disease states by finding probable causative variables risk stratification. Single-celled organisms, such as bacteria, even have SNPs. SNP genotyping can discriminate between microorganism isolates and might even be accustomed to characterizing antibiotic resistance strains. SNP-based strain detection has relevance in each clinical and pharmaceutical analysis and has been used to study the spread of infectious diseases in humans. Since these conditions are difficult to identify clinically, genotyping is the backbone of diagnostic testing in the population. This rising adoption of prenatal genetic screening to examine children's chromosomal anomalies could prove to be a significant driving factor.
Over the last decade, next-generation sequencing (NGS) technology has enabled simultaneous testing of multiple disease genes, from targeted gene panels to exome sequencing (ES) and genomic sequencing (GS). GS is quickly becoming a practical first-stage test as costs decrease and performance improves. More and more studies show that GS can detect an unprecedented range of pathogenic abnormalities in a single laboratory. GS has the potential to provide patients with unbiased, rapid, and accurate molecular diagnostics that transcend diverse clinical indications and complex conditions. Therefore, the use in drug development for genetic and rare diseases across the region will act as one of the key factors driving the growth of the genotyping markets.
North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
North America Genotyping Market Segmentation
The North America genotyping market is segmented by products and services, technology, application, end user, and country. Based on products and services, the market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagents and kits segment is dominating the market in 2022.
Based on technology, the market is segmented into microarrays, capillary electrophoresis, sequencing, matrix-assisted laser desorption/ionization-time of flight (Maldi-ToF) mass spectrometry, polymerase chain reaction (PCR), and others. The PCR segment is dominating the market in 2022.
Based on application, the market is segmented into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. The diagnostics and personalized medicine segment is dominating the market in 2022.
Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others. The diagnostics and research laboratories segment is dominating the market in 2022.
Based on country, the market is segmented into the US, Canada, and Mexico. Further, the US is dominating the market in 2022.
A few key players dominating the North America genotyping market are BioTek Instruments, Inc.; Eurofins Genomics; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Integrated DNA Technologies, Inc.; MERCK KGaA; QIAGEN; Thermo Fisher Scientific Inc; and TrimGen Corporation.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Genotyping Market - By Product and Services
1.3.2 North America Genotyping Market - By Technology
1.3.3 North America Genotyping Market - By Application
1.3.4 North America Genotyping Market - By End User
1.3.5 North America Genotyping Market - By Country
2. North America Genotyping Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Genotyping Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. North America Genotyping Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Use of Genotyping in Drug Development for Genetic and Rare Diseases
5.1.2 Technological Advancements and Rising R&D Investments in Pharmaceutical and Biotechnology
5.2 Market Restraints
5.2.1 High Cost of Equipment and Shortage of skilled Professionals required for Genotyping process
5.3 Market Opportunities
5.3.1 Wide Applications of Genotyping
5.4 Future Trends
5.4.1 Rising focus on Personalized Medicine
5.5 Impact analysis
6. Genotyping Market- North America Analysis
6.1 North America Genotyping Market Revenue Forecast and Analysis
7. North America Genotyping Market- by Product and Services
7.1 Overview
7.2 North America Genotyping Market, By Product and Services, 2022 & 2028 (%)
7.3 Reagents and Kits
7.3.1 Overview
7.3.2 Reagents and Kits: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Genotyping Services
7.4.1 Overview
7.4.2 Genotyping Services: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Bioinformatics
7.5.1 Overview
7.5.2 Bioinformatics: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Instruments
7.6.1 Overview
7.6.2 Instruments: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
8. North America Genotyping Market- by Technology
8.1 Overview
8.2 North America Genotyping Market Share by Technology - 2022 & 2028 (%)
8.3 Polymerase Chain Reaction (PCR)
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.4 Capillary Electrophoresis (CE)
8.4.1 Overview
8.4.2 Capillary Electrophoresis: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.5 Sequencing
8.5.1 Overview
8.5.2 Sequencing: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.6 Microarrays
8.6.1 Overview
8.6.2 Microarrays: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.7 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry
8.7.1 Overview
8.7.2 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9. North America Genotyping Market-by Application
9.1 Overview
9.2 North America Genotyping Market Share by Application - 2022 & 2028 (%)
9.3 Diagnostics and Personalized Medicine
9.3.1 Overview
9.3.2 Diagnostics and Personalized Medicine: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.4 Pharmacogenomics
9.4.1 Overview
9.4.2 Pharmacogenomics: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.5 Animal Genetics
9.5.1 Overview
9.5.2 Animal Genetics: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.6 Agricultural Biotechnology
9.6.1 Overview
9.6.2 Agricultural Biotechnology: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10. North America Genotyping Market- by End User
10.1 Overview
10.2 North America Genotyping Market Share by End User- 2022 & 2028 (%)
10.3 Diagnostic and Research Laboratories
10.3.1 Overview
10.3.2 Diagnostic and Research Laboratories: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.4 Pharmaceutical and Biopharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biopharmaceutical Companies: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.5 Academic Institutes
10.5.1 Overview
10.5.2 Academic Institutes: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
11. North America Genotyping Market- Country Analysis
11.1 North America: Genotyping Market Revenue and Forecasts to 2028
11.1.1 Overview
11.1.3 North America: Genotyping Market, by Country, 2022 & 2028 (%)
11.1.3.1 US: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3.1.1 Overview
11.1.3.1.2 US: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3.1.3 US: Genotyping Market, by Product and Services, 2019-2028 (US$ Million)
11.1.3.1.4 US: Genotyping Market, by Technology, 2019-2028 (US$ Million)
11.1.3.1.5 US: Genotyping Market, by Application, 2019-2028 (US$ Million)
11.1.3.1.6 US: Genotyping Market, by End User, 2019-2028 (US$ Million)
11.1.3.2 Canada: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3.2.1 Overview
11.1.3.2.2 Canada: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3.2.3 Canada: Genotyping Market, by Product and Services, 2019-2028 (US$ Million)
11.1.3.2.4 Canada: Genotyping Market, by Technology, 2019-2028 (US$ Million)
11.1.3.2.5 Canada: Genotyping Market, by Application, 2019-2028 (US$ Million)
11.1.3.2.6 Canada: Genotyping Market, by End User, 2019-2028 (US$ Million)
11.1.3.3 Mexico: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3.3.1 Overview
11.1.3.3.2 Mexico: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3.3.3 Mexico: Genotyping Market, by Product and Services, 2019-2028 (US$ Million)
11.1.3.3.4 Mexico: Genotyping Market, by Technology, 2019-2028 (US$ Million)
11.1.3.3.5 Mexico: Genotyping Market, by Application, 2019-2028 (US$ Million)
11.1.3.3.6 Mexico: Genotyping Market, by End User, 2019-2028 (US$ Million)
12. North America Genotyping Market Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 INTEGRATED DNA TECHNOLOGIES, INC. (DANAHER)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MERCK KGaA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 EUROFINS GENOMICS
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.6 THERMO FISHER SCIENTIFIC INC.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BioTek Instruments, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 TRIMGEN CORPORATION
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 SWOT Analysis
13.8.5 Key Developments
13.9 Illumina, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. The pharmaceutical company partnered with genomic health databases
Table 2. North America Genotyping Market -Revenue and Forecast to 2028 (US$ Million)
Table 3. US Genotyping Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Genotyping Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 6. US Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Genotyping Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Genotyping Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico: Genotyping Market, by Product and Services - Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico: Genotyping Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Genotyping Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Genotyping Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 15. Organic Developments Done By Companies
Table 16. Inorganic Developments Done By Companies
Table 17. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Genotyping Market Segmentation
Figure 2. North America Genotyping Market - By Country
Figure 3. North America Genotyping Market Overview
Figure 4. Reagents and Kits Held Largest Share by Product and Services of North America Genotyping Market
Figure 5. US to Show Significant Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Genotyping Market Impact Analysis of Driver and Restraints
Figure 9. North America Genotyping Market- Revenue Forecast and Analysis - 2022 - 2028
Figure 10. North America Genotyping Market, by Product and Services, 2022 & 2028 (%)
Figure 11. Reagents and Kits: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Genotyping Services: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Bioinformatics: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Instruments: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. North America Genotyping Market Share by Technology - 2022 & 2028 (%)
Figure 16. Polymerase Chain Reaction: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. Capillary Electrophoresis: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Sequencing: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Microarrays: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 20. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Others: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. North America Genotyping Market Share by Application - 2022 & 2028 (%)
Figure 23. Diagnostics and Personalized Medicine: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Pharmacogenomics: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Animal Genetics: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Agricultural Biotechnology: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Others: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. North America Genotyping Market Share by End User- 2022 & 2028 (%)
Figure 29. Diagnostic and Research Laboratories: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 30. Pharmaceutical and Biopharmaceutical Companies: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Academic Institutes: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Others: North America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. North America: Genotyping Market, by Key Country - Revenue (2022) (US$ Million)
Figure 34. North America: Genotyping Market, by Country, 2022 & 2028 (%)
Figure 35. US: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Canada: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Mexico: Genotyping Market - Revenue and Forecast to 2028 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security